JP2017212998A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017212998A5 JP2017212998A5 JP2017136828A JP2017136828A JP2017212998A5 JP 2017212998 A5 JP2017212998 A5 JP 2017212998A5 JP 2017136828 A JP2017136828 A JP 2017136828A JP 2017136828 A JP2017136828 A JP 2017136828A JP 2017212998 A5 JP2017212998 A5 JP 2017212998A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- group
- nos
- sequence selected
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 42
- 102000039446 nucleic acids Human genes 0.000 claims 42
- 108020004707 nucleic acids Proteins 0.000 claims 42
- 239000013612 plasmid Substances 0.000 claims 2
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161508366P | 2011-07-15 | 2011-07-15 | |
| US61/508,366 | 2011-07-15 | ||
| US201261601409P | 2012-02-21 | 2012-02-21 | |
| US61/601,409 | 2012-02-21 | ||
| US201261610212P | 2012-03-13 | 2012-03-13 | |
| US61/610,212 | 2012-03-13 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520317A Division JP6214530B2 (ja) | 2011-07-15 | 2012-07-12 | 転写活性化因子様エフェクターの組立て方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019043522A Division JP2019122392A (ja) | 2011-07-15 | 2019-03-11 | 転写活性化因子様エフェクターの組立て方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017212998A JP2017212998A (ja) | 2017-12-07 |
| JP2017212998A5 true JP2017212998A5 (enExample) | 2018-03-15 |
Family
ID=47558397
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520317A Active JP6214530B2 (ja) | 2011-07-15 | 2012-07-12 | 転写活性化因子様エフェクターの組立て方法 |
| JP2017136828A Withdrawn JP2017212998A (ja) | 2011-07-15 | 2017-07-13 | 転写活性化因子様エフェクターの組立て方法 |
| JP2019043522A Pending JP2019122392A (ja) | 2011-07-15 | 2019-03-11 | 転写活性化因子様エフェクターの組立て方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520317A Active JP6214530B2 (ja) | 2011-07-15 | 2012-07-12 | 転写活性化因子様エフェクターの組立て方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019043522A Pending JP2019122392A (ja) | 2011-07-15 | 2019-03-11 | 転写活性化因子様エフェクターの組立て方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20140274812A1 (enExample) |
| EP (2) | EP2732038B1 (enExample) |
| JP (3) | JP6214530B2 (enExample) |
| AU (3) | AU2012284365B2 (enExample) |
| CA (1) | CA2841710C (enExample) |
| WO (1) | WO2013012674A1 (enExample) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140274812A1 (en) | 2011-07-15 | 2014-09-18 | The General Hospital Corporation | Methods of Transcription Activator Like Effector Assembly |
| WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| WO2013017950A1 (en) * | 2011-07-29 | 2013-02-07 | Cellectis | High throughput method for assembly and cloning polynucleotides comprising highly similar polynucleotidic modules |
| US9890364B2 (en) | 2012-05-29 | 2018-02-13 | The General Hospital Corporation | TAL-Tet1 fusion proteins and methods of use thereof |
| EP2906602B1 (en) | 2012-10-12 | 2019-01-16 | The General Hospital Corporation | Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins |
| CA2900338C (en) | 2013-02-07 | 2024-11-05 | The General Hospital Corporation | TRANSCRIPTIONAL ACTIVATORS TALE |
| WO2014204578A1 (en) | 2013-06-21 | 2014-12-24 | The General Hospital Corporation | Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing |
| US10378027B2 (en) * | 2013-03-15 | 2019-08-13 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
| US10760064B2 (en) | 2013-03-15 | 2020-09-01 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
| US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| CN106459995B (zh) | 2013-11-07 | 2020-02-21 | 爱迪塔斯医药有限公司 | 使用统治型gRNA的CRISPR相关方法和组合物 |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| CN103789840A (zh) * | 2014-02-07 | 2014-05-14 | 赛业（广州）生物科技有限公司 | 一种tale聚体库的构建方法 |
| US11028388B2 (en) | 2014-03-05 | 2021-06-08 | Editas Medicine, Inc. | CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa |
| US11339437B2 (en) | 2014-03-10 | 2022-05-24 | Editas Medicine, Inc. | Compositions and methods for treating CEP290-associated disease |
| CA2948728A1 (en) | 2014-03-10 | 2015-09-17 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10) |
| US11141493B2 (en) | 2014-03-10 | 2021-10-12 | Editas Medicine, Inc. | Compositions and methods for treating CEP290-associated disease |
| WO2015148863A2 (en) | 2014-03-26 | 2015-10-01 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating sickle cell disease |
| EP3126495A1 (en) | 2014-04-02 | 2017-02-08 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating primary open angle glaucoma |
| WO2015153889A2 (en) * | 2014-04-02 | 2015-10-08 | University Of Florida Research Foundation, Incorporated | Materials and methods for the treatment of latent viral infection |
| EP3142706A1 (en) * | 2014-05-16 | 2017-03-22 | Vrije Universiteit Brussel | Genetic correction of myotonic dystrophy type 1 |
| WO2016022363A2 (en) | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| EP3286571B1 (en) | 2015-04-24 | 2021-08-18 | Editas Medicine, Inc. | Evaluation of cas9 molecule/guide rna molecule complexes |
| US9512446B1 (en) | 2015-08-28 | 2016-12-06 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
| US9926546B2 (en) | 2015-08-28 | 2018-03-27 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
| US9840542B2 (en) * | 2015-09-11 | 2017-12-12 | Nomadogen Biotechnologies Inc. | Methods and compositions for the packaging of nucleic acids into microglial exosomes for the targeted expression of polypeptides in neural cells |
| SG10202104041PA (en) | 2015-10-23 | 2021-06-29 | Harvard College | Nucleobase editors and uses thereof |
| WO2017165862A1 (en) | 2016-03-25 | 2017-09-28 | Editas Medicine, Inc. | Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency |
| CA3032822A1 (en) | 2016-08-02 | 2018-02-08 | Editas Medicine, Inc. | Compositions and methods for treating cep290 associated disease |
| KR20250103795A (ko) | 2016-08-03 | 2025-07-07 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| SG11201903089RA (en) | 2016-10-14 | 2019-05-30 | Harvard College | Aav delivery of nucleobase editors |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| EP3592381A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Cancer vaccine |
| US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| WO2018165629A1 (en) | 2017-03-10 | 2018-09-13 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| EP3596217A1 (en) | 2017-03-14 | 2020-01-22 | Editas Medicine, Inc. | Systems and methods for the treatment of hemoglobinopathies |
| WO2018176009A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| EP3622070A2 (en) | 2017-05-10 | 2020-03-18 | Editas Medicine, Inc. | Crispr/rna-guided nuclease systems and methods |
| WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| CN111801345A (zh) | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物 |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
| WO2019118949A1 (en) | 2017-12-15 | 2019-06-20 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US11667941B2 (en) | 2018-01-12 | 2023-06-06 | Camena Bioscience Limited | Compositions and methods for template-free geometric enzymatic nucleic acid synthesis |
| US20200405884A1 (en) * | 2018-03-09 | 2020-12-31 | Board Of Regents, The University Of Texas System | Crispr-nanoparticles and methods of use in brain disorders |
| KR102907245B1 (ko) | 2018-03-14 | 2026-01-05 | 에디타스 메디신, 인코포레이티드 | 혈색소병증 치료를 위한 시스템 및 방법 |
| US12312383B2 (en) | 2018-04-18 | 2025-05-27 | Altius Institute For Biomedical Sciences | Animal pathogen-derived polypeptides and uses thereof for genetic engineering |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| WO2020006126A1 (en) | 2018-06-27 | 2020-01-02 | Altius Institute For Biomedical Sciences | Nucleic acid binding domains and methods of use thereof |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12590324B2 (en) | 2019-01-14 | 2026-03-31 | Camena Bioscience Limited | Compositions and methods for template-free geometric enzymatic nucleic acid synthesis |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| EP3942043A2 (en) | 2019-03-19 | 2022-01-26 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| BR112022022603A2 (pt) | 2020-05-08 | 2023-01-17 | Broad Inst Inc | Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla |
Family Cites Families (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4186183A (en) | 1978-03-29 | 1980-01-29 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in chemotherapy of leishmaniasis |
| US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
| US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4603044A (en) | 1983-01-06 | 1986-07-29 | Technology Unlimited, Inc. | Hepatocyte Directed Vesicle delivery system |
| US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US4774085A (en) | 1985-07-09 | 1988-09-27 | 501 Board of Regents, Univ. of Texas | Pharmaceutical administration systems containing a mixture of immunomodulators |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US4957773A (en) | 1989-02-13 | 1990-09-18 | Syracuse University | Deposition of boron-containing films from decaborane |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| AU7979491A (en) | 1990-05-03 | 1991-11-27 | Vical, Inc. | Intracellular delivery of biologically active substances by means of self-assembling lipid complexes |
| US6900306B2 (en) | 2001-08-01 | 2005-05-31 | Isis Pharmaceuticals, Inc. | Antisense modulation of CoREST expression |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| AU672969B2 (en) | 1992-03-10 | 1996-10-24 | United States of America, as represented by The Secretary, Department of Health & Human Services, The | Exchangeable template reaction |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| EP0702716A4 (en) | 1993-05-17 | 1999-05-26 | Univ California | RIBOZYMIC GENE THERAPY FOR HIV INFECTION AND AIDS |
| AU685506B2 (en) | 1993-08-25 | 1998-01-22 | Systemix, Inc. | Method for producing a highly enriched population of hematopoietic stem cells |
| DE4343591A1 (de) | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes |
| CA2196419C (en) | 1994-08-20 | 2007-08-21 | Yen Choo | Improvements in or relating to binding proteins for recognition of dna |
| GB9618544D0 (en) | 1996-09-05 | 1996-10-16 | Brax Genomics Ltd | Characterising DNA |
| US6335195B1 (en) | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| US6440734B1 (en) | 1998-09-25 | 2002-08-27 | Cytomatrix, Llc | Methods and devices for the long-term culture of hematopoietic progenitor cells |
| DE19812103A1 (de) | 1998-03-19 | 1999-09-23 | Bernauer Annette | Verfahren zur Synthese von Nucleinsäuremolekülen |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6599692B1 (en) | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| DE19925862A1 (de) | 1999-06-07 | 2000-12-14 | Diavir Gmbh | Verfahren zur Synthese von DNA-Fragmenten |
| US8137906B2 (en) * | 1999-06-07 | 2012-03-20 | Sloning Biotechnology Gmbh | Method for the synthesis of DNA fragments |
| US20020164575A1 (en) | 1999-09-14 | 2002-11-07 | Sangamo Biosciences, Inc., A Delaware Corporation | Gene identification |
| HK1049515B (en) | 1999-12-06 | 2006-01-13 | Sangamo Biosciences Inc. | Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| WO2001053480A1 (en) | 2000-01-24 | 2001-07-26 | Sangamo Biosciences, Inc. | Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules |
| WO2001083819A2 (en) | 2000-04-28 | 2001-11-08 | Sangamo Biosciences, Inc. | Methods for designing exogenous regulatory molecules |
| EP1276860B1 (en) | 2000-04-28 | 2007-09-26 | Sangamo Biosciences Inc. | Databases of regulatory sequences; methods of making and using same |
| CA2407695C (en) | 2000-04-28 | 2015-03-31 | Sangamo Biosciences, Inc. | Methods for binding an exogenous molecule to cellular chromatin |
| ATE353361T1 (de) | 2000-04-28 | 2007-02-15 | Sangamo Biosciences Inc | Gezielten modifikation der chromatinstruktur |
| US7029847B2 (en) | 2000-05-16 | 2006-04-18 | Massachusetts Institute Of Technology | Methods and compositions for interaction trap assays |
| US6492117B1 (en) | 2000-07-12 | 2002-12-10 | Gendaq Limited | Zinc finger polypeptides capable of binding DNA quadruplexes |
| US6667064B2 (en) | 2000-08-30 | 2003-12-23 | Pilot Therapeutics, Inc. | Composition and method for treatment of hypertriglyceridemia |
| JP2002262870A (ja) * | 2000-11-09 | 2002-09-17 | Nara Institute Of Science & Technology | 固相において二本鎖ｄｎａ分子を順次連結する方法およびその装置 |
| AU2002225187A1 (en) | 2001-01-22 | 2002-07-30 | Sangamo Biosciences, Inc. | Zinc finger polypeptides and their use |
| GB0108491D0 (en) | 2001-04-04 | 2001-05-23 | Gendaq Ltd | Engineering zinc fingers |
| WO2004099366A2 (en) | 2002-10-23 | 2004-11-18 | The General Hospital Corporation | Context sensitive parallel optimization of zinc finger dna binding domains |
| US7198165B2 (en) | 2004-05-20 | 2007-04-03 | Graham Packaging Pet Technologies Inc. | Molded plastic hot-fill container and method of manufacture |
| EP1833981B1 (en) | 2004-12-16 | 2012-04-18 | President and Fellows of Harvard College | Histone demethylation mediated by the nuclear amine oxidase homolog lsd1 |
| WO2007053480A2 (en) | 2005-10-28 | 2007-05-10 | The University Of North Carolina At Chapel Hill | Protein demethylases comprising a jmjc domain |
| GB0607063D0 (en) | 2006-04-07 | 2006-05-17 | Cellcentric Ltd | Compositions and methods for epigenetic modification of nucleic acid sequences in vivo |
| JP5266210B2 (ja) | 2006-05-25 | 2013-08-21 | サンガモ バイオサイエンシズ インコーポレイテッド | 改変開裂ハーフドメイン |
| BRPI0817447A8 (pt) | 2007-09-28 | 2016-12-27 | Two Blades Found | Molécula isolada ou recombinante de ácido nuceico, cassete de expressão, vetor, planta transformada, célula hospedeira não-humana, métodos para aumentar a resistência de uma planta a pelo menos um patógeno de planta, para expressar um gene de interesse em uma planta ou célula de planta, para expressar genes em alto nível em uma planta ou célula de planta, e para causar morte celular em uma parte da planta de interesse, e, polipeptídeo isolado |
| JP2011523353A (ja) | 2008-04-28 | 2011-08-11 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | 細胞透過のための過剰に荷電されたタンパク質 |
| PL2274430T3 (pl) | 2008-04-30 | 2017-09-29 | Sanbio Inc | Komórki regenerujące nerwy ze zmianami w metylacji DNA |
| WO2010037001A2 (en) | 2008-09-26 | 2010-04-01 | Immune Disease Institute, Inc. | Selective oxidation of 5-methylcytosine by tet-family proteins |
| AR075356A1 (es) | 2008-11-10 | 2011-03-30 | Two Blades Foundation | Promotores inducibles por patogenos y su uso en el mejoramiento de la resistencia a las enfermedades en plantas |
| EP2206723A1 (en) * | 2009-01-12 | 2010-07-14 | Bonas, Ulla | Modular DNA-binding domains |
| US9221886B2 (en) | 2009-04-28 | 2015-12-29 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
| WO2011017293A2 (en) * | 2009-08-03 | 2011-02-10 | The General Hospital Corporation | Engineering of zinc finger arrays by context-dependent assembly |
| EP3156504B1 (en) | 2009-08-11 | 2018-10-31 | Sangamo Therapeutics, Inc. | Organisms homozygous for targeted modification |
| US8889394B2 (en) | 2009-09-07 | 2014-11-18 | Empire Technology Development Llc | Multiple domain proteins |
| NO2510096T3 (enExample) * | 2009-12-10 | 2015-03-21 | ||
| WO2011097036A1 (en) | 2010-02-08 | 2011-08-11 | Sangamo Biosciences, Inc. | Engineered cleavage half-domains |
| EP3156062A1 (en) * | 2010-05-17 | 2017-04-19 | Sangamo BioSciences, Inc. | Novel dna-binding proteins and uses thereof |
| JP5996630B2 (ja) * | 2011-04-05 | 2016-09-21 | セレクティスＣｅｌｌｅｃｔｉｓ | コンパクトｔａｌｅ−ヌクレアーゼを作製する方法及びその使用 |
| US20140274812A1 (en) | 2011-07-15 | 2014-09-18 | The General Hospital Corporation | Methods of Transcription Activator Like Effector Assembly |
| WO2013017950A1 (en) * | 2011-07-29 | 2013-02-07 | Cellectis | High throughput method for assembly and cloning polynucleotides comprising highly similar polynucleotidic modules |
| US9890364B2 (en) | 2012-05-29 | 2018-02-13 | The General Hospital Corporation | TAL-Tet1 fusion proteins and methods of use thereof |
| JP2015527889A (ja) | 2012-07-25 | 2015-09-24 | ザ ブロード インスティテュート， インコーポレイテッド | 誘導可能なｄｎａ結合タンパク質およびゲノム撹乱ツール、ならびにそれらの適用 |
| EP2906602B1 (en) | 2012-10-12 | 2019-01-16 | The General Hospital Corporation | Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins |
| CA2900338C (en) | 2013-02-07 | 2024-11-05 | The General Hospital Corporation | TRANSCRIPTIONAL ACTIVATORS TALE |
| US10378027B2 (en) | 2013-03-15 | 2019-08-13 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
-
2012
- 2012-07-12 US US14/232,067 patent/US20140274812A1/en not_active Abandoned
- 2012-07-12 EP EP12814750.1A patent/EP2732038B1/en not_active Not-in-force
- 2012-07-12 JP JP2014520317A patent/JP6214530B2/ja active Active
- 2012-07-12 EP EP18191841.8A patent/EP3461896B1/en active Active
- 2012-07-12 CA CA2841710A patent/CA2841710C/en active Active
- 2012-07-12 AU AU2012284365A patent/AU2012284365B2/en not_active Ceased
- 2012-07-12 WO PCT/US2012/046451 patent/WO2013012674A1/en not_active Ceased
-
2016
- 2016-05-17 US US15/156,574 patent/US10273271B2/en active Active
-
2017
- 2017-07-13 AU AU2017204819A patent/AU2017204819A1/en not_active Abandoned
- 2017-07-13 JP JP2017136828A patent/JP2017212998A/ja not_active Withdrawn
-
2019
- 2019-02-22 US US16/283,380 patent/US11472849B2/en active Active
- 2019-03-11 JP JP2019043522A patent/JP2019122392A/ja active Pending
- 2019-09-06 AU AU2019226213A patent/AU2019226213A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019122392A5 (enExample) | ||
| JP2016034981A5 (enExample) | ||
| JP2021505201A5 (enExample) | ||
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| CN109937252A (zh) | 重组dna聚合酶 | |
| JP2015533791A5 (enExample) | ||
| JP2016187361A5 (enExample) | ||
| NZ612405A (en) | Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests | |
| JP2017505117A5 (enExample) | ||
| JP2009540801A5 (enExample) | ||
| JP2016104790A5 (enExample) | ||
| JP2010088434A5 (enExample) | ||
| JP2019528793A5 (enExample) | ||
| JP2019214579A5 (enExample) | ||
| JP2015128433A5 (enExample) | ||
| JP2014193147A5 (enExample) | ||
| JP2015119721A5 (enExample) | ||
| HRP20200471T1 (hr) | Tonoplastni protonsko/šećerni antiporterski proteini i njihova upotreba u povećavanju koncentracije saharoze u biljnom organu za skladištenje saharoze | |
| BR112017011621A2 (pt) | gene n?au resistente ao vírus do mosaico do tabaco e métodos de clonagem e suas aplicações | |
| HRP20241279T1 (hr) | Pripravak koji sadrži probiotike koji prekomjerno eksprimiraju protein clpb za uporabu u liječenju pretilosti | |
| JP2018534946A5 (enExample) | ||
| JP2017529868A5 (enExample) | ||
| JP2020513810A5 (enExample) | ||
| RU2018142174A (ru) | Контролируемая пищевым рационом экспрессия нуклеиновой кислоты, кодирующей нуклеазу cas9, и ее применения | |
| HRP20201945T1 (hr) | Postupak proizvodnje gonadotropina |